{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:03:34Z","timestamp":1761894214993},"reference-count":10,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2006,4,1]],"date-time":"2006-04-01T00:00:00Z","timestamp":1143849600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2006,4]]},"DOI":"10.1016\/j.jns.2005.11.021","type":"journal-article","created":{"date-parts":[[2006,1,19]],"date-time":"2006-01-19T19:00:46Z","timestamp":1137697246000},"page":"97-99","source":"Crossref","is-referenced-by-count":45,"title":["Antimyoclonic effect of levetiracetam in MERRF syndrome"],"prefix":"10.1016","volume":"243","author":[{"given":"Michelangelo","family":"Mancuso","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renato","family":"Galli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiara","family":"Pizzanelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Massimiliano","family":"Filosto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriele","family":"Siciliano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luigi","family":"Murri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jns.2005.11.021_bib1","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S1474-4422(05)70043-0","article-title":"Progressive myoclonic epilepsies: a review of genetic and therapeutic aspects","volume":"4","author":"Shahwan","year":"2005","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.jns.2005.11.021_bib2","first-page":"217","article-title":"Clinical features and genetics of myoclonic epilepsy with ragged red fibers","volume":"89","author":"DiMauro","year":"2002","journal-title":"Adv Neurol"},{"key":"10.1016\/j.jns.2005.11.021_bib3","first-page":"66","article-title":"Treatment of myoclonus","volume":"103","author":"Van Zandijcke","year":"2003","journal-title":"Acta Neurol Belg"},{"key":"10.1016\/j.jns.2005.11.021_bib4","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1196\/annals.1293.023","article-title":"Mitochondrial encephalomyopathies: therapeutic approach","volume":"1011","author":"Dimauro","year":"2004","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.jns.2005.11.021_bib5","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1212\/01.WNL.0000127608.48406.F1","article-title":"A novel mitochondrial tRNAPhe mutation causes MERRF syndrome","volume":"62","author":"Mancuso","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2005.11.021_bib6","first-page":"280","article-title":"Myoclonic epilepsy and ragged-red fibers (MERRF): a mitochondrial tRNALys mutation responsive to Coenzyme Q10 (CoQ) therapy (abs)","volume":"41","author":"Wallace","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2005.11.021_bib7","first-page":"209","article-title":"Antimyoclonic effect of levetiracetam","volume":"2","author":"Genton","year":"2000","journal-title":"Epil Dis"},{"key":"10.1016\/j.jns.2005.11.021_bib8","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1111\/j.0013-9580.2004.56902.x","article-title":"Antimyoclonic effect of levetiracetam in 13 patients with Unverricht\u2013Lundborg disease: clinical observations","volume":"45","author":"Magaudda","year":"2004","journal-title":"Epilepsia"},{"key":"10.1016\/j.jns.2005.11.021_bib9","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1212\/01.WNL.0000110193.78872.DD","article-title":"Levetiracetam in progressive myoclonic epilepsy: an exploratory study in 9 patients","volume":"62","author":"Crest","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2005.11.021_bib10","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.parkreldis.2004.07.010","article-title":"Limited efficacy of levetiracetam on myoclonus of different etiologies","volume":"11","author":"Lim","year":"2005","journal-title":"Parkinsonism Relat Disord"}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X0500434X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X0500434X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,19]],"date-time":"2019-01-19T03:50:30Z","timestamp":1547869830000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X0500434X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,4]]},"references-count":10,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2006,4]]}},"alternative-id":["S0022510X0500434X"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2005.11.021","relation":{},"ISSN":["0022-510X"],"issn-type":[{"value":"0022-510X","type":"print"}],"subject":[],"published":{"date-parts":[[2006,4]]}}}